Clinical outcomes of chemical pleurodesis using a minocycline
Background: Pleurodesis is often used to prevent the re-accumulation of a malignant pleural effusion (MPE). Intrapleural urokinase (IPUK) therapy facilitates lung re-expansion for patients with loculated MPE or a trapped lung that allows subsequent pleurodesis. MPE management has been traditionally...
Main Authors: | Li-Han Hsu, An-Chen Feng, Thomas C. Soong, Jen-Sheng Ko, Nei-Min Chu, Yung-Feng Lin, Shu-Huei Kao |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-04-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466619841231 |
Similar Items
-
The Inflammatory Cytokine Profile of Patients with Malignant Pleural Effusion Treated with Pleurodesis
by: Li-Han Hsu, et al.
Published: (2020-12-01) -
Video-Assisted Thoracoscopic Surgery for Primary Spontaneous Pneumothorax: Effects and Mechanisms of Additional Minocycline Pleurodesis
by: Jin-Shing Chen, et al.
Published: (2004) -
Chemical pleurodesis for spontaneous pneumothorax
by: Cheng-Hung How, et al.
Published: (2013-12-01) -
Chemical pleurodesis for malignant pleural effusion
by: W. Shouman, et al.
Published: (2012-07-01) -
The impact of repeated thoracentesis on the outcome of chemical pleurodesis in malignant pleural effusion
by: Adel Salah, et al.
Published: (2012-10-01)